PMID- 21625915 OWN - NLM STAT- MEDLINE DCOM- 20120427 LR - 20220408 IS - 1559-0720 (Electronic) IS - 0163-4984 (Linking) VI - 144 IP - 1-3 DP - 2011 Dec TI - Effect of boron on osteogenic differentiation of human bone marrow stromal cells. PG - 306-15 LID - 10.1007/s12011-011-9094-x [doi] AB - Bone marrow stromal cells (BMSCs) have been well established as an ideal source of cell-based therapy for bone tissue engineering applications. Boron (B) is a notable trace element in humans; so far, the effects of boron on the osteogenic differentiation of BMSCs have not been reported. The aim of this study was to evaluate the effects of boron (0, 1, 10,100, and 1,000 ng/ml) on osteogenic differentiation of human BMSCs. In this study, BMSCs proliferation was analyzed by cell counting kit-8 (CCK8) assay, and cell osteogenic differentiation was evaluated by alkaline phosphatase (ALP) activity assay, Von Kossa staining, and real-time PCR. The results indicated that the proliferation of BMSCs was no different from the control group when added with B at the concentration of 1, 10, and 100 ng/ml respectively (P > 0.05); in contrast, 1,000 ng/ml B inhibited the proliferation of BMSCs at days 4, 7, and 14 (P < 0.05). By ALP staining, we discovered that BMSCs treated with 10 and 100 ng/ml B presented a higher ALP activity compared with control (P < 0.05). By real-time PCR, we detected the messenger RNA expression of ALP, osteocalcin, collagen type I, and bone morphogenetic proteins 7 were also increased in 10 and 100 ng/ml B treatment groups (P < 0.05). The calcium depositions were increased in 1 and 10 ng/ml B treatment groups (P < 0.05). Taken all together, it was the first time to report that B could increase osteogenic effect by stimulating osteogenic differentiation-related marker gene synthesis during the proliferation and differentiation phase in human BMSCs and could be a promising approach for enhancing osteogenic capacity of cell-based construction in bone tissue engineering. FAU - Ying, Xiaozhou AU - Ying X AD - Department of Orthopaedic Surgery, The Second Affiliated Hospital of Wenzhou Medical College, 109 Xue Yuan Xi Road, Wenzhou, 325000, China. FAU - Cheng, Shaowen AU - Cheng S FAU - Wang, Wei AU - Wang W FAU - Lin, Zhongqin AU - Lin Z FAU - Chen, Qingyu AU - Chen Q FAU - Zhang, Wei AU - Zhang W FAU - Kou, Dongquan AU - Kou D FAU - Shen, Yue AU - Shen Y FAU - Cheng, Xiaojie AU - Cheng X FAU - Rompis, Ferdinand An AU - Rompis FA FAU - Peng, Lei AU - Peng L FAU - Zhu Lu, Chuan AU - Zhu Lu C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110531 PL - United States TA - Biol Trace Elem Res JT - Biological trace element research JID - 7911509 RN - 0 (Bone Morphogenetic Protein 7) RN - 0 (Boric Acids) RN - 0 (Boron Compounds) RN - 0 (Collagen Type I) RN - 0 (DNA Primers) RN - 0 (Genetic Markers) RN - 0 (RNA, Messenger) RN - 104982-03-8 (Osteocalcin) RN - EC 3.1.3.1 (Alkaline Phosphatase) RN - R57ZHV85D4 (boric acid) RN - SY7Q814VUP (Calcium) SB - IM MH - Alkaline Phosphatase/metabolism MH - Bone Marrow Cells/*drug effects MH - Bone Morphogenetic Protein 7/metabolism MH - Boric Acids/pharmacology MH - Boron Compounds/*pharmacology MH - Calcium/metabolism MH - Cell Count MH - Cell Differentiation/drug effects/genetics MH - Cell Proliferation/drug effects MH - Cell Separation MH - Cells, Cultured MH - Collagen Type I/biosynthesis MH - DNA Primers MH - Dose-Response Relationship, Drug MH - Genetic Markers MH - Humans MH - Osteocalcin/biosynthesis MH - Osteogenesis/*drug effects/genetics MH - Phenotype MH - RNA, Messenger/biosynthesis/genetics MH - Real-Time Polymerase Chain Reaction MH - Stromal Cells/*drug effects EDAT- 2011/06/01 06:00 MHDA- 2012/04/28 06:00 CRDT- 2011/06/01 06:00 PHST- 2011/04/07 00:00 [received] PHST- 2011/05/19 00:00 [accepted] PHST- 2011/06/01 06:00 [entrez] PHST- 2011/06/01 06:00 [pubmed] PHST- 2012/04/28 06:00 [medline] AID - 10.1007/s12011-011-9094-x [doi] PST - ppublish SO - Biol Trace Elem Res. 2011 Dec;144(1-3):306-15. doi: 10.1007/s12011-011-9094-x. Epub 2011 May 31.